New Providers Enter German NIPT Market While Reimbursement Remains Elusive | GenomeWeb

NEW YORK (GenomeWeb) – Competition between providers of DNA-based noninvasive prenatal screening tests in Germany has increased over the last year, with several local laboratories that process samples within the country's borders entering the market, BGI offering its test through a partner, and other firms, including Premaitha Health, in the starting blocks.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.